Immunovia successfully completes discovery phase of next-generation test development

Go back to Immunovia successfully completes discovery phase of next-generation test development
(NASDAQ: OLK) Delayed: 26.08 --0 (-0%)
Previous Close $26.08    52 Week High $ 
Open $26.08    52 Week Low $ 
Day High $26.08    P/E N/A 
Day Low $26.08    EPS $ 
Volume 15,296